Phosphorylation-dependent modulation of the vanilloid receptor TRPV1 is one of the key mechanisms mediating the hyperalgesic effects of inflammatory mediators, such as prostaglandin E 2 (PGE 2 ). However, little is known about the molecular organization of the TRPV1 phosphorylationcomplexandspecificallyaboutscaffoldingproteinsthatpositiontheproteinkinaseA(PKA)holoenzymeproximaltoTRPV1foreffective and selective regulation of the receptor. Here, we demonstrate the critical role of the A-kinase anchoring protein AKAP150 in PKA-dependent modulation of TRPV1 function in adult mouse dorsal root ganglion (DRG) neurons. We found that AKAP150 is expressed in ϳ80% of TRPV1-positive DRG neurons and is coimmunoprecipitated with the capsaicin receptor. In functional studies, PKA stimulation with forskolin markedly reduced desensitization of TRPV1. This effect was blocked by the PKA selective inhibitors KT5720 [(9S,10R,12R)-2,3,9,10,11,12-hexahydro-10-hydroxy-9-methyl-1-oxo-9,
Introduction
The vanilloid receptor TRPV1 is an important molecular integrator of pain-producing stimuli that is highly expressed in nociceptive C and A␦ fibers. TRPV1 functions as a transducer channel activated by noxious heat, acidic pH, or lipid-derived endovanilloids, which enables nociceptors to respond to a range of noxious stimuli with an electrical discharge (Caterina and Julius, 2001; Szallasi et al., 2006) . Studies using TRPV1 knock-out mice and TRPV1 selective antagonists have demonstrated that TRPV1 is essential for the development of inflammatory thermal hyperalgesia (Caterina et al., 2000; Davis et al., 2000; Gavva et al., 2005; Cui et al., 2006) . Accordingly, TRPV1 has been functionally linked to a number of chronic pain conditions associated with inflammation, including arthritic pain, cancer pain, visceral pain, and migraine (Ghilardi et al., 2005; Jones et al., 2005; Keeble et al., 2005; Szallasi et al., 2006) , and several drugs targeting TRPV1 are now in clinical trials (Immke and Gavva, 2006) .
How does TRPV1 contribute to heat hyperalgesia? A key step in this process is thought to be TRPV1 sensitization by inflammatory mediators released at the site of injury, such as prostaglandins, bradykinin, and serotonin. By acting via G-proteincoupled receptors, these mediators stimulate protein kinase A (PKA) and protein kinase C (PKC) to induce phosphorylation of TRPV1. Phosphorylation, in turn, significantly reduces the thermal activation threshold of TRPV1, rendering nociceptors more sensitive to lower temperatures, and also sensitizes TRPV1 to capsaicin, protons, and endovanilloids (Bhave and Gereau, 2004; Nagy et al., 2004; Tominaga and Tominaga, 2005) . Despite the acknowledged functional importance of TRPV1 phosphorylation, little is known about the molecular organization of the TRPV1 phosphorylation complex.
Scaffolding and adaptor proteins are central to the assembly and function of multiprotein signaling complexes. Members of the A-kinase anchoring protein (AKAP) family of scaffolding proteins bind the regulatory subunit of PKA and facilitate association of the enzyme with its intracellular substrates at distinct subcellular loci (Beene and Scott, 2007) . Two recent reports showed that the AKAP inhibitory peptide Ht31 blocks TRPV1 sensitization in sensory neurons (Rathee et al., 2002; Sugiura et al., 2004) . However, Ht31 does not discriminate among members of this large, diverse family of AKAP proteins, which differ in their tissue distribution, subcellular localization, and signaling function (Wong and Scott, 2004) . Therefore, the important question of which specific AKAP regulates phosphorylation and sensitization of TRPV1 remains unanswered.
(0.2 mg/ml in 150 mM boric buffer) and laminin (0.5 mg/ml in PBS; Roche Diagnostics) coated glass coverslips. Cells were grown in DMEM supplemented with 5% heat-inactivated horse serum, 5% heatinactivated fetal bovine serum, 50 ng/ml NGF, 6 g/ml insulin, 0.5 U/ml penicillin, and 0.5 g/ml streptomycin, pH 7.4, and maintained at 37°C in a humidified atmosphere of 5% CO 2 . Experiments were performed 2 d after plating.
Transfection of DRG neurons was performed before plating, using an Amaxa Biosystems (Gaithersburg, MD) electroporation system. For each transfection reaction, DRG neurons obtained from one to two mice were mixed with 5 g of plasmid DNA in 100 l of Amaxa Biosystems buffer and electroporated according to the protocol of the manufacturer (program G-13). The plasmids encoding AKAP79 -enhanced yellow fluorescent protein (EYFP) and AKAP250 -enhanced green fluorescent protein (EGFP) were provided by Dr. Mark Dell'Acqua (University of Colorado, Denver, CO), the AKAP15/18 -EGFP plasmid was provided by Dr. John Scott (Vollum Institute, Portland, OR) , and the dual specificity (D)-AKAP2-EGFP plasmid was provided by Dr. Rory Fisher (University of Iowa, Iowa City, IA). D-AKAP1-EGFP was prepared by isolating the core domain of rat D-AKAP1 (residues 1-522) using reverse-transcriptase PCR and fusing to the N terminus of EGFP. The EYFP plasmid (pEYFP-N1) was obtained from Clontech/Takara (Mountain View, CA).
Immunostaining. DRG neurons were washed in PBS followed by 20 min fixation with 4% paraformaldehyde. Cells were washed three times for 5 min each with PBS and then treated with blocking solution (5% donkey serum and 0.1% Triton X-100 in PBS). Cells were incubated with goat polyclonal anti-TRPV1 (10 g/ml; R&D Systems, Minneapolis, MN) and rabbit polyclonal anti-AKAP150 (1:200; Upstate, Lake Placid, NY) primary antibodies overnight at 4°C. After being washed in blocking solution (five times for 5 min each), cells were incubated with donkey anti-goat FITC-labeled and donkey anti-rabbit tetramethylrhodamine isothiocyanate-labeled (1:200; Jackson ImmunoResearch, West Grove, PA) secondary antibodies for 30 min at 22°C. Cells were subsequently washed with PBS (five times for 5 min each) and then mounted on slides using Fluoromount-G (Southern Biotechnology Associates, Birmingham, AL). Images were captured using an Olympus (Tokyo, Japan) BX61WI microscope equipped with the Fluoview 300 laser-scanning confocal imaging system and a 60ϫ oil immersion objective [numerical aperture (NA), 1.40].
Immunoprecipitation and immunoblotting. Adult mouse brain, spinal cord, and dorsal root ganglia were harvested immediately after anesthesia and decapitation of C57BL/6 mice. Tissues were homogenized in ice-cold buffer containing 50 mM Tris-HCl, pH 7.4, 150 mM NaCl, 5 mM EDTA, 1 mM EGTA, and 1% Triton X-100 and supplemented with protease inhibitors (1 g/ml pepstatin A, 10 g/ml leupeptin, 20 g/ml aprotinin, and 200 nM phenylmethanesulfonyl fluoride). Nonsolubilized material was pelleted for 30 min at 40,000 rpm in a Beckman Ti-70 rotor (Beckman Coulter, Fullerton, CA). To determine expression profiles of different AKAP subtypes in mouse nervous tissue, protein concentration was estimated by a BCA assay, and 50 g of protein was loaded on the gels. Protein was extracted by boiling in SDS sample buffer, separated by SDS-PAGE, transferred to polyvinylidene fluoride membranes (0.45 m; Millipore, Billerica, MA), and probed for the presence of AKAP isoforms. Rabbit anti-AKAP15 antibody (1:1000 dilution) was a generous gift from Dr. William Catterall (University of Washington, Seattle, WA), rabbit anti-AKAP150 antibody (1:1000 dilution) was from Upstate (Lake Placid, NY), mouse anti-AKAP250 antibody (1:2000 dilution) was from Abcam (Cambridge, MA), and rabbit anti-Yotiao antibody (1:250 dilution) was from Zymed Laboratories (Carlsbad, CA). TRPV1-AKAP complexes were detected by immunoprecipitating TRPV1 from spinal cord lysates (five animals per experiment) or DRG lysates (three to six animals per experiment) using 3 g of rabbit anti-TRPV1 antibody (catalog #RA14113; Neuromics, Edina, MN) and 30 l of prewashed protein-A beads (ϳ50% slurry; Santa Cruz Biotechnology, Santa Cruz, CA) for 4 h; immunoprecipitates were washed three times with 0.1% Triton X-100 in TBS (20 mM Tris-HCl and 150 mM NaCl). Probing was done using the Neuromics anti-TRPV1 antibody (1:500 dilution) and the various anti-AKAP antibodies listed above. Specificity of the TRPV1 antibody was confirmed by blotting immunoprecipitates with other TRPV1 antibodies either from Neuromics (N-terminus rabbit anti-TRPV1) or from Calbiochem (San Diego, CA) (Ab-2 rabbit anti-TRPV1). Association of PKA with AKAP150 was detected by immunoprecipitating AKAP150 from spinal cord lysate and probing with the rabbit anti-PKA RII␣ antibody (M-20) (1:500 dilution; Santa Cruz Biotechnology). TRPV1-PKA association was examined by immunoprecipitating TRPV1 with 3 g of the goat anti-TRPV1 antibody (R&D Systems, Minneapolis, MN) and probing for PKA RII␣. Control immunoprecipitations were performed with 3 g of purified rabbit (Zymed Laboratories) or goat IgG that originated from nonimmunized animals (Jackson ImmunoResearch).
Calcium imaging. The standard extracellular HEPES-buffered HBSS (HH buffer) contained the following (in mM): 140 NaCl, 5 KCl, 1.3 CaCl 2 , 0.4 MgSO 4 , 0.5 MgCl 2 , 0.4 KH 2 PO 4 , 0.6 NaHPO 4 , 3 NaHCO 3 , 10 glucose, and 10 HEPES, pH 7.35 with NaOH (310 mOsm/kg with sucrose). DRG neurons were incubated for 25 min with 2 M of the AM form of fura-2 at room temperature (22°C). Cells were placed in a flowthrough chamber mounted on the stage of an inverted IX-71 microscope (Olympus) and washed for 10 min before the experiment. Fluorescence was alternately excited at 340 (12 nm bandpass) and 380 (12 nm bandpass) using the Polychrome IV monochromator (T.I.L.L. Photonics, Martinsried, Germany), via either a 20ϫ objective (NA 0.75; Olympus) or a 40ϫ oil immersion objective (NA 1.35; Olympus). Emitted fluorescence was collected at 510 (80) nm using an IMAGO CCD camera (T.I.L.L. Photonics). Pairs of 340/380 nm images were sampled at 0.2 Hz. The fluorescence ratio (R ϭ F 340 /F 380 ) was converted to [Ca 2ϩ ] i according to the formula [Ca 2ϩ (Grynkiewicz et al., 1985) . The dissociation constants (K d ) used for fura-2 was 225 nM (Invitrogen Handbook; Invitrogen, Carlsbad, CA). R min , R max , and ␤ were determined by applying 10 M ionomycin in Ca 2ϩ -free buffer (1 mM EGTA) and HH buffer (1.3 mM Ca 2ϩ ). Calibration constants for the 20ϫ objective were as follows: R min ϭ 0.21, R max ϭ 3.45, and ␤ ϭ 6.97. For the 40ϫ objective, calibration constants were as follows: R min ϭ 0.17, R max ϭ 2.71, and ␤ ϭ 5.64. Fluorescence was corrected for background, as determined in an area that did not contain a cell. Data were processed using TILLvisION 4.0.1.2 (T.I.L.L. Photonics) and Origin 7.0 (Microcal Software, Northhampton, MA) software and presented as mean Ϯ SEM.
Electrophysiology. Whole-cell patch-clamp recordings (V hold of Ϫ60 mV) were obtained using a patch-clamp amplifier Axopatch 200B and an analog-to-digital converter Digidata 1322A (Molecular Devices, Union City, CA). Patch pipettes were pulled from borosilicate glass (3-5 M⍀; Narishige, Tokyo, Japan) on a P-87 micropipette puller (Sutter Instruments, Novato, CA) and filled with the following solution (in mM): 125 K-gluconate, 10 KCl, 10 NaCl, 0.5 Na-GTP, 3 Mg-ATP, 1 MgCl 2 , 0.2 EGTA, and 10 HEPES, pH 7.25 adjusted with KOH (290 mOsm/kg with sucrose). The standard extracellular recording solution contained the following: 50 mM NaCl, 90 mM choline-Cl, 5 mM KCl, 1.3 mM CaCl 2 , 0.4 mM MgSO 4 , 0.5 mM MgCl 2 , 0.4 mM KH 2 PO 4 , 0.6 mM Na 2 HPO 4 , 3 mM NaHCO 3 , 10 mM glucose, 10 mM HEPES, and 1 M tetrodotoxin, pH 7.35 with NaOH (310 mOsm/kg with sucrose). Heat-evoked currents were induced by superfusing cells with preheated solution, which enabled a temperature increase from room temperature to ϳ48°C at a rate of 1.2-1.6°C/s. Temperature was monitored by using a bead thermistor TA-29 (Warner Instruments, Hamden, CT) positioned within 100 m from the cell and connected to a single-channel heater controller TC-324BHT (Warner Instruments). Data were collected (filtered at 1 kHz and sampled at 2.5 kHz) and analyzed using the pClamp 9 software (Molecular Devices) and presented as mean Ϯ SEM.
Behavioral testing. All experiments were performed in male adult (8 -12 week old) C57BL/6 (Taconic Farms) and ⌬36 mice using a protocol approved by the University of Iowa Institutional Animal Care and Use Committee. Every effort was made to minimize the number of mice and their suffering. Thermal sensitivity was examined by measuring pawwithdrawal latency in response to a radiant heat stimulus applied to the plantar surface of the hindpaw (Hargreaves et al., 1988) . Time to pawwithdrawal reflex was determined electronically. Mice were acclimated to the testing room and equipment for 3 d (2 h/d) and also for at least 1 h before testing. PGE 2 (100 ng) was injected subcutaneously into the plantar surface of one hindpaw in a volume of 10 l. In some experiments, Ht31 (8 g) was coinjected with PGE 2 in the same total volume of 10 l. Paw-withdrawal latency was measured at 15, 30, 60, and 90 min after the injection. The baseline latency was determined before the injection by averaging the results of three tests separated by a 5 min interval. Mice were used only once and received only one dose of drug or drug combination.
Reagents. -pyrrole-2,5-dione) , and tetrodotoxin were purchased from Tocris (Ellisville, MO), membrane-permeable stearated forms of the Ht31 and Ht31P peptides were obtained from Promega (Madison, WI), phorbol-12,13-dibutyrate (PdBu) and PGE 2 were from Calbiochem, KT5720 [(9S,10 R,12 R)-2,3,9,10,11,12-hexahydro-10-hydroxy-9-methyl-1-oxo-9,12-epoxy-1 H-diindolo[1,2,3-fg:3Ј,2Ј,1Ј-kl] pyrrolo [3,4-i] - [1, 6] benzodiazocine-10-carboxylicacid hexyl ester] was from Alomone Labs (Jerusalem, Israel), and fura-2 AM was from Invitrogen. All other reagents were from Sigma (St. Louis, MO).
Results

TRPV1 and AKAP150 are coexpressed and coimmunoprecipitate in DRG neurons
To identify PKA anchoring proteins that could potentially interact with TRPV1, we first examined which AKAPs are expressed in DRG and the spinal cord of adult mice. Both DRG and the spinal cord are rich in TRPV1, in which the receptor is found on the cell bodies and on the central processes of primary nociceptors, respectively (Tominaga et al., 1998; Guo et al., 1999; Caterina et al., 2000; Malin et al., 2006) . We studied expression of four different AKAPs that have been shown to associate with other ion channels and receptors: AKAP15/18, AKAP150, AKAP250, and Yotiao (Wong and Scott, 2004) . Immunoblots obtained from DRG and spinal cord lysates were compared with those obtained from brain, in which these AKAPs have been characterized previously (Tibbs et al., 1998; Westphal et al., 1999; Colledge et al., 2000; Piontek and Brandt, 2003; Hall et al., 2007; Lu et al., 2007) .
Probing with an anti-AKAP15/18-specific antibody revealed two strongly immunoreactive bands in lysates from brain and DRG and one in spinal cord lysate (Fig. 1 A) . The AKAP15/18 gene (Gene Nomenclature Committee name AKAP7) is subject to splicing, which gives rise to the lower molecular weight (15/18 kDa) ␣ and ␤ isoforms that are targeted to the cell membrane and to a higher molecular weight (ϳ35 kDa) ␥ isoform that is cytoplasmic (Trotter et al., 1999) . In the brain, AKAP15/18 was shown to associate with voltage-gated Na ϩ (Na v 1.2a) and Ca 2ϩ (Ca v 1.2) channels (Tibbs et al., 1998; Cantrell et al., 2002; . AKAP15/18 is also expressed in cardiac and skeletal muscles, in which it interacts with the L-type Ca 2ϩ channel to facilitate PKA-dependent phosphorylation of the channel (Gray et al., 1997 Fraser et al., 1998; Hulme et al., 2003) .
As shown in Figure 1 A, AKAP150 (Gene Nomenclature Committee name AKAP5; also known as AKAP79) is robustly expressed in the spinal cord and DRG. Previous studies showed that AKAP79/150 is abundant at the postsynaptic sites of glutamatergic synapses in which it facilitates PKA-dependent phosphorylation of AMPA and NMDA glutamate receptors, thereby contributing to synaptic plasticity (Colledge et al., 2000; Gomez et al., 2002; Lu et al., 2007) . AKAP79/150 also associates with the L-type (Ca v 1.2) Ca 2ϩ channels (Gao et al., 1997; Hall et al., 2007) , M-type (KCNQ2/3) K ϩ channels (Hoshi et al., 2003) , ASIC1a and 2a channels (Chai et al., 2007) , and ␤2-adrenergic receptor (Fraser et al., 2000) .
We found that AKAP250, also known as gravin (Gene Nomenclature Committee name AKAP12), is expressed in both spinal cord and DRG, whereas the AKAP Yotiao, which is a ϳ230 kDa splice variant of the AKAP450 gene (Gene Nomenclature Committee name AKAP 9), is expressed in DRG but undetectable in spinal cord lysate (Fig. 1 A) . Like AKAP150 (Fraser et al., 2000) , AKAP250 assembles with the ␤ 2 -adrenergic receptor (Shih et al., 1999; Tao et al., 2003) . Yotiao interacts with the NMDA (NR1A subunit) receptor in the brain (Lin et al., 1998; Westphal et al., 1999) and also associates with and facilitates phosphorylation of the slow K ϩ channel I Ks in the heart (Kurokawa et al., 2004) . We next examined which of these AKAPs interact with TRPV1. Using a TRPV1-specific antibody, we found that only AKAP150, but not any other tested AKAP, coimmunoprecipitated with the TRPV1 channel in spinal cord and DRG. Immunoblots of TRPV1 immunoprecipitates revealed that AKAP150 specifically and reproducibly (five independent experiments using spinal cord from 27 animals and nine experiments using DRG from 40 animals) associated with TRPV1 ( Fig. 1 B) . Coimmunoprecipitation of AKAP150 with TRPV1 was specific, because nonimmune control antibodies failed to isolate either of these proteins (IgG lanes in Fig. 1 B) .
Immunostaining revealed that AKAP150 is expressed in ϳ77% of DRG neurons (303 of 394), present in all size groups, and its expression pattern matches the overall size distribution (Fig. 1C) . TRPV1 is expressed in ϳ47% of DRG neurons (185 of 394), consistent with observations by others (Negri et al., 2006; Hjerling-Leffler et al., 2007) . The majority of TRPV1-expressing cells (ϳ80%) also showed AKAP150 immunofluorescence that was highly concentrated near the plasma membrane ( Fig. 1 D, red) . Approximately 39% of DRG neurons showed immunostaining for AKAP150 but not for TRPV1 (154 of 394), whereas ϳ14% showed neither AKAP150 nor TRPV1 immunofluorescence (55 of 394) ( Fig. 1 E) .
Disruption of PKA anchoring by AKAP150 inhibits PKA-dependent modulation of TRPV1
TRPV1 function is strongly dependent on its phosphorylation state. The receptor is at least partially phosphorylated in the resting state Mandadi et al., 2006) . TRPV1 is highly permeable for Ca 2ϩ [P Ca /P Na ϭ 9.6 (Caterina et al., 1997)], and Ca 2ϩ influx via TRPV1 induces Ca 2ϩ /calcineurin-dependent dephosphorylation and desensitization of the receptor (Cholewinski et al., 1993; Koplas et al., 1997; Mohapatra and Nau, 2005) . In turn, phosphorylation by PKA prevents desensitization of TRPV1 and enhances its function Nau, 2003, 2005) . To study TRPV1 regulation by PKA, we adapted the desensitization protocols developed by several other groups (Hu et al., 2002; Yang and Gereau, 2002; Mohapatra and Nau, 2003; Mandadi et al., 2004) . Capsaicin-induced Ca 2ϩ influx was measured by using Ca 2ϩ imaging, which has been established as a reliable tool to monitor TRPV1 activity in intact neurons (Caterina et al., 1997; Greffrath et al., 2001; Savidge et al., 2001; Hu et al., 2002; Malin et al., 2006) . First, we examined the time course of TRPV1 desensitization (tachyphylaxis) in adult mouse DRG neurons by studying changes in cytosolic Ca 2ϩ concentration ([Ca 2ϩ ] i ) induced by two successive capsaicin applications (100 nM for 10 s). Stimulations with capsaicin were separated by various time intervals ranging from 3 to 60 min (Fig. 2 Figure 1 . AKAP150 is associated with TRPV1 in DRG neurons. A, DRG neurons express multiple AKAPs. Western blots of lysates of adult mouse brain, spinal cord, and DRG tissue were probed with antibodies against Yotiao, AKAP250, AKAP150, AKAP15/18, and ␣-tubulin, respectively (3-5 independent experiments, 12-20 animals). B, AKAP150 -TRPV1 complexes were isolated from adult mouse spinal cord (top) and DRG (bottom) membrane fractions. Immunoprecipitations (IP) were performed with an antibody against TRPV1 or control IgG. Immunoprecipitates were separated by SDS-PAGE and probed with antibodies against Yotiao, AKAP250, AKAP150, AKAP15/18, and TRPV1, respectively (spinal cord: 5 independent experiments, 27 animals; DRG: 9 independent experiments, 40 animals). C, Histogram shows size (cross-sectional area of the cell body) distribution of AKAP150-positive DRG neurons relative to all neurons. D, Immunostaining shows subcellular distribution of TRPV1 (left) and AKAP150 (right) in a DRG neuron expressing both proteins. E, Pie chart shows the proportion of DRG neurons expressing AKAP150 (red), TRPV1 (green), both proteins (yellow), or none (white) in culture.
2002). We found that TRPV1 channels were strongly desensitized when two capsaicin applications were separated by only 3 min ( Fig. 2 A) ; the response ratio under these conditions was 0.11 Ϯ 0.03 (n ϭ 51 cells/14 animals). As shown in Figure 2 , TRPV1 slowly recovered from desensitization, and the [Ca 2ϩ ] i response to capsaicin was fully restored within an hour (response ratio, 1.11 Ϯ 0.22; n ϭ 22 cells/4 animals).
For additional studies, we chose the 3 min protocol, for which TRPV1 channels are most strongly desensitized under control conditions (Fig. 3A) . Desensitization of TRPV1 was markedly reduced by the treatment of cells with 10 M forskolin, an activator of adenylate cyclase and thereby PKA (response ratio, 0.51 Ϯ 0.09; n ϭ 73 cells/14 animals) (Fig. 3 B, G) . Pretreating DRG neurons with the PKA-selective inhibitors H89 (N-[2-( p-bromocinnamylamino)-ethyl]-5-isoquinoline-sulfon-amide 2HCl) (10 M) (Fig. 3C ) or KT5720 (1 M) (Fig. 3D ) blocked the forskolin effect on TRPV1, reducing the response ratio to 0.12 Ϯ 0.05 (n ϭ 20 cells/6 animals) (Fig. 3C,G) and 0.17 Ϯ 0.05 (n ϭ 36 cells/4 animals) (Fig. 3 D, G) , respectively. Preincubation with these inhibitors had no effect on either the amplitude of the [Ca 2ϩ ] i response to the first capsaicin application (1360 Ϯ 320 nM in control, n ϭ 51 cells/12 animals; 2190 Ϯ 550 nM for H89, n ϭ 23 cells/2 animals; 1280 Ϯ 250 nM for KT5720, n ϭ 17 cells/4 animals; p Ͼ 0.05, one-way ANOVA with Bonferroni's post hoc test) or TRPV1 desensitization in cells that had not been treated with forskolin (response ratio, 0.11 Ϯ 0.03 in control, n ϭ 51 cells/12 animals; response ratio, 0.08 Ϯ 0.04 for H89, n ϭ 23 cells/2 animals; response ratio, 0.07 Ϯ 0.03 for KT5720, n ϭ 17 cells/4 animals; p Ͼ 0.05, one-way ANOVA with Bonferroni's post hoc test).
Forskolin-induced increase of cAMP concentration could also potentially lead to activation of Epac (guanine exchange protein activated by cAMP) (Holz et al., 2006) . Epac, in turn, has been linked to phospholipase C (PLC)-dependent activation of PKC in sensory neurons (Hucho et al., 2005) . However, we found that addition of the specific Epac activator CPTOMe (10 M) to the extracellular solution before the second capsaicin application had no effect on TRPV1 desensitization. The response ratio for the CPTOMe-treated cells was 0.16 Ϯ 0.06 (n ϭ 39 cells/2 animals), which was not significantly different from that in control (untreated) cells (Fig. 3 A, G) ( p Ͼ 0.05, one-way ANOVA with Bonferroni's post hoc test). Moreover, the forskolin-induced reduction in desensitization was not affected by treating cells with the PLC inhibitor U73122 (1 M; 10 min pretreatment). The response ratio for the cells treated with a combination of 10 M forskolin and 1 M U73122 was 0.46 Ϯ 0.11 (n ϭ 65 cells/3 animals). This is not significantly different from the response ratio obtained for cells treated with forskolin alone (Fig. 3 B, G) ( p Ͼ 0.05, one-way ANOVA with Bonferroni's post hoc test). These data, together with the findings that two structurally different PKA inhibitors, H89 and KT5720, completely blocked the effect of forskolin, suggest that forskolininduced reduction of TRPV1 desensitization was mediated primarily by PKA.
We next examined the role of PKA signaling in the immediate vicinity of TRPV1. Functional coupling of PKA to its cellular substrates is mediated by AKAP proteins (Wong and Scott, 2004; Dell'Acqua et al., 2006) . The Ht31 peptide encompasses the PKA regulatory subunit binding site of AKAPs and is widely used to competitively dissociate PKA/AKAP complexes. Ht31 has been shown to redistribute a pool of PKA holoenzymes from the cell membrane to the cytoplasm (Hundsrucker et al., 2006) . Preincubation of cells with a membrane-permeable stearated form of the Ht31 peptide (50 M) abolished the forskolin effect on TRPV1, reducing the response ratio to 0.12 Ϯ 0.05 (n ϭ 17 cells/6 animals) (Fig. 3 E, G) . In contrast, treatment with the control Ht31P peptide, which contains two amino acid substitutions that abrogate the binding to PKA, did not interfere with the effect of forskolin (response ratio, 0.65 Ϯ 0.15; n ϭ 11 cells/4 animals) (Fig.  3 F, G) .
Next, we specifically addressed the role of PKA anchoring by AKAP150 in PKA-mediated reduction of TRPV1 desensitization. AKAP150 contains binding sites for PKA, PKC, and calcineurin (Fig. 4 A) and is involved in regulating AMPA receptors, M-type K ϩ and L-type Ca 2ϩ channels, and acid sensing ion channels (Gao et al., 1997; Tavalin et al., 2002; Hoshi et al., 2003; Chai et al., 2007; Hall et al., 2007) . We have recently described ⌬36 knock-in mice, in which WT AKAP150 is replaced by a mutant that is truncated by 36 residues to specifically remove the PKA binding domain (Fig. 4 A) (Lu et al., 2007) . Coimmunoprecipitation using an AKAP150-specific antibody shows that PKA association with AKAP150 is indeed disrupted in these mice (Fig. 4 B) . Furthermore, immunoprecipitation using a TRPV1-specific antibody demonstrates that both AKAP150 and the PKA regulatory subunit PKA RII␣ associate with TRPV1 in WT mice. In contrast, the PKA-TRPV1 interaction was disrupted in ⌬36 mice, although the mutant AKAP150-⌬36 protein was still present in the immunoprecipitation complex (Fig. 4C) . These data are consistent with the idea that PKA association with TRPV1 is mediated by AKAP150.
The functional significance of AKAP150 was tested by studying TRPV1 desensitization in DRG neurons from homozygous ⌬36 mice using the 3 min capsaicin paired-pulse protocol described in Figure 3 . Amplitudes of [Ca 2ϩ ] i responses to the first capsaicin application were no different between DRG neurons from WT and ⌬36 mice (WT, 1360 Ϯ 320 nM, n ϭ 51 cells/12 animals; ⌬36, 1200 Ϯ 170 nM, n ϭ 47 cells/10 animals; p ϭ 0.68, Student's t test). TRPV1 desensitization was also similar in DRG neurons from WT and ⌬36 mice under control conditions (Fig.  4 D, F ) . However, forskolin revealed a striking difference between DRG neurons from WT and ⌬36 mice. We found that the ability of forskolin to prevent TRPV1 desensitization was strongly impaired in DRG neurons from ⌬36 mice (Fig. 4 E, F ) , yielding a response ratio of only 0.20 Ϯ 0.05 (n ϭ 45 cells/10 animals); the response ratio was not significantly changed by pretreating cells with the PKA inhibitor KT5720 (Fig. 4 F) . Thus, PKA anchoring by AKAP150 is crucial for PKA-mediated reduction of TRPV1 desensitization in DRG neurons.
PKC-dependent sensitization of TRPV1 is unaltered in DRG neurons from ⌬36 mice Phosphorylation by PKC sensitizes TRPV1 to heat, protons, capsaicin, and endovanilloids (Premkumar and Ahern, 2000; Vellani et al., 2001; Numazaki et al., 2002; Bhave et al., 2003; Premkumar et al., 2004; Gold and Flake, 2005) . AKAP150 also directly binds PKC to bring the kinase in close proximity to its ion channel and receptor substrates (Wong and Scott, 2004) . The PKC-binding site is located near the N terminus of AKAP150 (Dell'Acqua et al., 2006) . Therefore, truncation of the PKA binding site at the C terminus of AKAP150 in ⌬36 mice (Fig. 4 A) is not expected to interfere with PKC binding to AKAP150. To examine whether the PKC-dependent pathway remains functional in DRG neurons from ⌬36 mice, we compared the effects of PKC stimulation on capsaicin-induced [Ca 2ϩ ] i responses in cells from WT and ⌬36 mice. We used the same 3 min paired-pulse protocol as described above (Figs. 3, 4) . We found that PKC stimulation using 500 nM PdBu strongly sensitized TRPV1 to capsaicin in DRG neurons from both WT and ⌬36 mice (Fig. 5 A, B) . In these experiments, response ratios were 3.42 Ϯ 0.88 (n ϭ 40 cells/10 animals) and 4.38 Ϯ 1.61 (n ϭ 64 cells/10 animals) for DRG neurons from WT and ⌬36 mice, respectively ( p ϭ 0.66, unpaired Student's t test). Also, some DRG neurons from WT mice (4 of 121 neurons, 10 animals) and ⌬36 mice (14 of 169 neurons, 10 animals) that initially failed to respond to 100 nM capsaicin exhibited a large capsaicin-induced [Ca 2ϩ ] i transient after pre- treatment with PdBu (Fig. 5C) . Overall, these data show that PKC-dependent modulation of TRPV1 is not affected in ⌬36 mice.
PKA anchoring by AKAP150 is important for PGE 2 -dependent modulation of TRPV1 PGE 2 is an important inflammatory mediator, and PGE 2 levels are increased at the periphery and in the CNS after tissue injury or inflammation (Svensson and Yaksh, 2002; Park and Vasko, 2005) . PGE 2 facilitates TRPV1 function in sensory neurons primarily via PKA-dependent phosphorylation of the receptor (Lopshire and Nicol, 1998; Southall and Vasko, 2001; Hu et al., 2002; Gu et al., 2003) , although a recent study suggests that PKC is also involved (Moriyama et al., 2005) . Using the 3 min pairedpulse protocol, we investigated the effect of PGE 2 on capsaicininduced [Ca 2ϩ ] i changes in DRG neurons from WT and ⌬36 mice. As shown in Figure 6 , treatment with 5 M PGE 2 markedly reduced TRPV1 desensitization in DRG neurons from WT mice, leading to a significant enhancement of the [Ca 2ϩ ] i response to the second capsaicin application and yielding a response ratio of 0.75 Ϯ 0.17 (n ϭ 31 cells/8 animals). The effect of PGE 2 on TRPV1 desensitization was significantly diminished in DRG neurons from ⌬36 mice (Fig. 6 B, E) , giving a response ratio of only 0.35 Ϯ 0.09 (n ϭ 33 cells/6 animals). In DRG neurons from both WT and ⌬36 mice, the effect of PGE 2 on TRPV1 was blocked by pretreatment with 1 M KT5720 (WT: response ratio, 0.17 Ϯ 0.04, n ϭ 24 cells/2 animals; ⌬36: response ratio, 0.17 Ϯ 0.06, n ϭ 37 cells/4 animals) (Fig. 6C-E) .
Ca 2ϩ imaging provides a powerful tool for studying Ca 2ϩ entry in a mixed population of cells, e.g., capsaicin-responding and nonresponding DRG neurons. However, the amplitude of , 2006) . In the truncated version of AKAP150 (AKAP150-⌬36), the last 36 amino acids of the C terminus are removed to disrupt PKA binding. B, PKA RII␣ associates with AKAP150 in WT but not in ⌬36 mice. AKAP150 was immunoprecipitated from Triton X-100 solubilized spinal cord membranes with an anti-AKAP150 antibody, and immunoprecipitates were analyzed by immunoblotting with an antibody against PKA RII␣ (4 independent experiments, 24 animals from each strain). C, PKA RII␣ coimmunoprecipitates with TRPV1 from adult mouse spinal cord in WT but not AKAP150-⌬36 mice. Immunoprecipitations were performed with an antibody against TRPV1 or nonimmune control antibodies, separated by SDS-PAGE, and probed with antibodies against AKAP150 and the regulatory subunit of PKA RII␣ (5 independent experiments, 27 animals from each strain). D, E, [Ca 2ϩ ] i elevations elicited by two stimulations with capsaicin (100 nM for 10 s, 3 min between the stimulations indicated by arrowheads) were recorded in DRG neurons from ⌬36 mice. Between capsaicin applications, cells were superfused with either control HH buffer (D) or HH buffer containing 10 M forskolin (FSK, horizontal bar) (E). F, Bar graph shows that the ability of forskolin to reduce TRPV1 desensitization was significantly impaired in DRG neurons from ⌬36 mice. Response ratios were obtained from experiments such as those shown in D and E and are presented as mean Ϯ SEM. For comparison between DRG neurons from WT (white bars) and ⌬36 (gray bars) mice, data for WT/control and WT/forskolin conditions were replotted from Figure 3G . **p Ͻ 0.01, one-way ANOVA with Bonferroni's post hoc test. the [Ca 2ϩ ] i response can also be affected by the Ca 2ϩ buffering processes. Therefore, we further examined the effects of PGE 2 by monitoring TRPV1-mediated currents directly, using patchclamp (Fig. 7) . In these patch-clamp experiments, whole-cell currents were evoked by two applications of capsaicin (1 M, 10 s) that were separated by 3 min. Capsaicin-induced currents strongly desensitized under control conditions, giving a response ratio (current amplitude 2 /current amplitude 1 ) of 0.25 Ϯ 0.04 (n ϭ 10 cells/5 animals) and 0.22 Ϯ 0.08 (n ϭ 6 cells/4 animals) in WT and ⌬36 DRG neurons, respectively. The desensitization was significantly reduced by the addition of 5 M PGE 2 to DRG neurons from WT (response ratio, 0.69 Ϯ 0.11; n ϭ 7 cells/4 animals) but not ⌬36 mice (response ratio, 0.29 Ϯ 0.09; n ϭ 5 cells/4 animals). Pretreating the cells with the PKA inhibitor KT5720 blocked the effect of PGE 2 (Fig. 7E) . In this latter case, the response ratio was 0.14 Ϯ 0.03 for WT DRG neurons (n ϭ 5 cells/3 animals) and 0.22 Ϯ 0.10 for DRG neurons from ⌬36 mice (n ϭ 4 cells/3 animals). Overall, the described [Ca 2ϩ ] i imaging and patch-clamp data demonstrate that PGE 2 -induced modulation of TRPV1 in sensory neurons is mediated by AKAP150-anchored PKA.
Expression of full-length AKAP79 rescues PGE 2 -dependent modulation of TRPV1 in ⌬36 mice Defective TRPV1 regulation in ⌬36 mice could be an indirect consequence of disrupted PKA signaling in these knock-in animals. We therefore examined whether the deficiency in PGE 2 /PKA-dependent enhancement of TRPV1 function in ⌬36 mouse DRG neurons could be acutely rescued by expressing the full-length human ortholog of AKAP150, AKAP79. This protein shares a high degree of homology and functional similarity with AKAP150 (Carr et al., 1992; Wong and Scott, 2004; Dell'Acqua et al., 2006) . The effect of AKAP79 was also compared with those of several other AKAPs characterized by distinct functions and subcellular localizations, including D-AKAP1, D-AKAP2, AKAP15/18, and AKAP250 (Nauert et al., 1997; Fraser et al., 1998; Tibbs et al., 1998; Huang et al., 1999; Trotter et al., 1999; Wang et al., 2001) . To this end, we transfected DRG neurons with either EYFP-or EGFP-tagged AKAP constructs or with EYFP alone using the Amaxa Biosystems electroporation system. EYFP distributed evenly throughout the cytoplasm (image in Fig. 8 A) , whereas AKAP79 -EYFP and AKAP15/18 -EGFP were concentrated at the cell periphery (images in Fig. 8 B, D) and the mitochondria-associated D-AKAP2 was distributed throughout the cell body excluding the nucleus (image in Fig. 8C ). The distribution of D-AKAP1 (data not shown) was similar to that of D-AKAP2, whereas AKAP250 was found both at the plasma membrane and in the cytosol (data not shown). Under control conditions, the TRPV1-mediated response in EYFP-transfected DRG neurons from WT mice was strongly desensitized after stimulation with capsaicin (response ratio, 0.03 Ϯ 0.02; n ϭ 21 cells/15 animals). Treatment with PGE 2 dramatically reduced TRPV1 desensitization in DRG neurons from WT mice (response ratio, 0.31 Ϯ 0.05; n ϭ 47 cells/15 animals). The effect of PGE 2 was strongly diminished in EYFP-transfected DRG neurons from ⌬36 mice (response ratio, 0.11 Ϯ 0.04; n ϭ 31 cells/7 animals) (Fig. 8 A) . The expression of AKAP79 -EYFP, but not of any other examined AKAP, restored the PGE 2 effect in DRG neurons from ⌬36 mice (Fig. 8 B-E) , yielding a response ratio of 0.41 Ϯ 0.14 (n ϭ 18 cells/11 animals). Thus, AKAP79 rescues the ⌬36 deficit in PGE 2 -dependent modulation of TRPV1.
PGE 2 -induced thermal hypersensitivity is diminished in ⌬36 mice
Under physiological conditions, TRPV1 is activated by heat above 42-43°C (Caterina et al., 1997; Tominaga et al., 1998) . Phosphorylation-dependent lowering of TRPV1 thermal activation threshold by inflammatory mediators is likely one of the key mechanisms contributing to thermal hyperalgesia after tissue injury or inflammation (Bhave and Gereau, 2004; Nagy et al., 2004; Immke and Gavva, 2006) . Accordingly, disruption of the TRPV1 gene or pharmacologic inhibition of TRPV1 strongly diminish inflammatory thermal hypersensitivity (Caterina et al., 2000; Davis et al., 2000; Gavva et al., 2005; Cui et al., 2006) . In particular, it has been shown that PGE 2 -induced thermal hyperalgesia is essentially eliminated in TRPV1 knock-out mice (Moriyama et al., 2005) . Given the marked deficit of TRPV1 modulation by PGE 2 in ⌬36 mice (Figs. 6, 7) , it is conceivable that PGE 2 -induced enhancement of thermal sensitivity is also impaired in these mice. To test this idea, we first compared the effects of PGE 2 on heat-activated currents in capsaicin-sensitive DRG neurons from WT and ⌬36 mice. Capsaicin sensitivity was determined by [Ca 2ϩ ] i imaging, as described above. Specifically, cells in which capsaicin application (100 nM, 10 s) induced a [Ca 2ϩ ] i elevation that was at least 100% higher than the resting [Ca 2ϩ ] i and reached 150 nM were chosen. Cells were washed of capsaicin for at least 1 h to enable a full recovery of TRPV1 from desensitization (Fig. 2) . Heat-activated currents were induced by applying temperature ramps (Fig. 9A) and were plotted as a function of extracellular temperature for additional analysis (Fig. 9B-E) , similar to the approach described by other groups (Sugiura et al., 2002 (Sugiura et al., , 2004 Moriyama et al., 2005) . Under control conditions, heat-activated currents in DRG neurons from WT and ⌬36 mice showed similar threshold temperatures (WT: 42.8 Ϯ 0.4°C, n ϭ 8 cells/5 animals; ⌬36: 41.6 Ϯ 0.7°C, n ϭ 8 cells/4 animals). These values are in good agreement with the temperature requirement for TRPV1 activation (Tominaga et al., 1998; Sugiura et al., 2002; Kim et al., 2006) , as well as with the thermal response thresholds reported for heat-activated currents in sensory neurons by others (Caterina et al., 2000; Davis et al., 2000; Rathee et al., 2002) . Exposure of cells to PGE 2 (5 M) produced a marked leftward shift in the temperature dependence of heat-activated currents in WT DRG neurons (temperature threshold, 34.3 Ϯ 0.6°C; n ϭ 12 cells/5 animals) (Fig. 9C ). This PGE 2 -induced temperature shift was significantly reduced in DRG neurons from ⌬36 mice B) . B-E, Heat-activated currents were induced as described in A and plotted as a function of extracellular temperature for DRG neurons from WT (B, C) and ⌬36 mice (D, E) under control conditions (B, D) or in the presence of 5 M PGE 2 (3 min pretreatment; C, E). Gray vertical arrows indicate threshold temperature for each plot, which was defined as the intersection between the lines (gray dotted lines) approximating the baseline and the clearly increasing temperature-dependent inward current (Sugiura et al., 2002 (Sugiura et al., , 2004 . F, Bar graph summarizes temperature thresholds of heat-activated currents in DRG neurons from WT (white bars) and ⌬36 (gray bars) mice, recorded under control conditions and after treatment with 5 M PGE 2 alone or in combination with either 1 M KT5720 (PGE 2 /KT) or 20 M Ht31 (PGE 2 /Ht). Ht31 was included in the pipette solution, and KT5720 was applied for 6 min before the recordings. **p Ͻ 0.01, ***p Ͻ 0.001, ANOVA with Bonferroni's post hoc test. G, PGE 2 -induced thermal hyperalgesia was studied in WT and ⌬36 mice. PGE 2 was injected into plantar surface of the hindpaw (100 ng in 10 l) of WT (n ϭ 16; square) or ⌬36 (n ϭ 11; triangle) mice or a mixture of PGE 2 plus Ht31 (100 ng ϩ 8 g in 10 l) was injected into plantar surface of a WT mouse hindpaw (n ϭ 15; circle). Paw-withdrawal latency to radiant heat was measured at various times after the injection. The baseline latency for each group (time ϭ 0 min) was determined before the injection by averaging the results of three tests separated by a 5 min interval. *p Ͻ 0.05, relative to WT/Ht31; # p Ͻ 0.05, relative to ⌬36; ANOVA with Bonferroni's post hoc test.
(38.5 Ϯ 0.9°C; n ϭ 8 cells/4 animals) (Fig. 9E) . It was also reduced in WT DRG neurons by pretreatment with the AKAP inhibitory peptide Ht31 (temperature threshold, 39.6 Ϯ 0.8°C; n ϭ 5 cells/3 animals). The PKA inhibitor KT5720 also blocked the PGE 2 effect in WT DRG neurons (temperature threshold, 39.1 Ϯ 1.3°C; n ϭ 7 cells/3 animals; p Ͻ 0.001), whereas an already small PGE 2 -induced temperature shift in ⌬36 DRG neurons was not further reduced by KT5720 (Fig. 9F ) (temperature threshold, 38.9 Ϯ 1.0°C; n ϭ 8 cells/3 animals; p Ͼ 0.05).
We further tested the role of AKAP150 in regulating thermal sensitivity by studying paw-withdrawal latency in response to a radiant heat stimulus (Hargreaves et al., 1988) in WT and ⌬36 mice. Both strains of mice showed similar paw-withdrawal latencies under the basal conditions (Fig. 9G, time ϭ 0) . These results are in agreement with the findings that heat-activated currents in DRG neurons from WT and ⌬36 had a similar threshold temperature under control conditions (Fig. 9F ) . Injection of PGE 2 (100 ng/10 l) into the plantar surface of the hindpaw induced thermal hyperalgesia that lasted for Ͼ1 h. The magnitude and the time course of the PGE 2 effect were consistent with those reported by other groups (Malmberg et al., 1997; Yang and Gereau, 2002; Moriyama et al., 2005) . Examination of ⌬36 mice showed that PGE 2 -induced hyperalgesia was significantly diminished in these animals (Fig. 9G) . Furthermore, coadministration of the membrane-permeable AKAP inhibitory peptide Ht31 to the hindpaw of WT mice also significantly decreased the PGE 2 effect.
Overall, the described behavioral data are in good agreement with the patch-clamp results and suggest that the PGE 2 -induced reduction of the heat-activated current temperature threshold is one of the key mechanisms contributing to thermal hyperalgesia in response to PGE 2 injection. Our data also suggest that the development of PGE 2 -induced thermal hyperalgesia critically depends on AKAP150-anchored PKA.
Discussion
This study demonstrates that PKA anchoring by AKAP150 is essential for the PGE 2 /PKA-dependent modulation of TRPV1 in mouse sensory neurons. Several lines of evidence support this conclusion. First, TRPV1 and AKAP150 are coexpressed in DRG neurons and coimmunoprecipitate. This coimmunoprecipitation indicates that AKAP150 and TRPV1 are in close proximity to each other, perhaps interacting with each other. Second, the disruption of PKA binding by the AKAP150 mutant in ⌬36 mice strongly diminished PGE 2 /PKA-dependent modulation of TRPV1. Overexpression of the full-length human ortholog of AKAP150, but not of other AKAPs, completely restored the ability of PGE 2 to enhance TRPV1 function in DRG neurons from ⌬36 mice. Finally, PGE 2 -induced thermal hypersensitivity was significantly diminished in ⌬36 mice. Phosphorylationdependent modulation of TRPV1 by inflammatory mediators is an important mechanism contributing to sensitization of nociceptors (Julius and Basbaum, 2001; Bhave and Gereau, 2004) , and our work establishes AKAP150 as a critical molecular component of the cellular machinery that controls this process.
The AKAP inhibitory peptide Ht31 has been shown previously to prevent potentiation of heat-and proton-activated currents by forskolin and serotonin, respectively (Rathee et al., 2002; Sugiura et al., 2004) . We found that Ht31 also blocked the effect of forskolin on TRPV1 function in our system (Fig. 3E) . By competing with endogenous AKAPs for binding to PKA regulatory subunits, Ht31 displaces the PKA holoenzyme from its cellular substrates (Hundsrucker et al., 2006) . Although previous studies using Ht31 have helped to establish the importance of PKA anchoring for TRPV1 regulation, they have not answered the question of which AKAP mediates this regulation. The AKAP family comprises Ͼ50 proteins that differ in their signaling function and tissue distribution (Wong and Scott, 2004) , and at least four AKAPs, including AKAP15/18, AKAP150, AKAP250, and Yotiao, are expressed in DRG (Fig. 1 A) . In this work, we provide evidence for the crucial role of AKAP150 in directing PKA activity at TRPV1 in sensory neurons.
AKAP150 is expressed in the majority of TRPV1-positive DRG neurons and is highly concentrated at the plasma membrane (Fig. 1 D) . Moreover, AKAP79 -EYFP concentrated near the plasma membrane when it was overexpressed in DRG neurons (Fig. 8 B) . TRPV1 is also present at the plasma membrane but, overall, shows a more widespread distribution throughout the cell body (Fig. 1 D) . Other groups have reported similar TRPV1 distribution in rodent DRG neurons both in vivo and in vitro (Guo et al., 1999; Rathee et al., 2002; Zwick et al., 2002; Liu et al., 2003; Malin et al., 2006) . It is likely that intracellular TRPV1 immunofluorescence reflects an association of the receptor with the endoplasmic reticulum and Golgi complex (Guo et al., 1999; Liu et al., 2003; Karai et al., 2004) . In all DRG neurons that expressed both TRPV1 and AKAP150, these proteins colocalized near the plasma membrane. More convincing evidence for association of these proteins was obtained by showing that AKAP150, but not AKAP15/18, AKAP250, or Yotiao, coimmunoprecipitates with TRPV1 from DRG and spinal cord (Fig. 1 B) . Moreover, PKA RII␣ is associated with TRPV1 in WT but not in ⌬36 mice (Fig. 4C) . Combined, our data imply a signaling complex containing TRPV1, AKAP150, and PKA (Fig. 4C) . Whether AKAP150 and TRPV1 interact directly or via membraneassociated scaffold proteins, such as the membrane-associated guanylate kinase family proteins (Colledge et al., 2000) , remains to be investigated.
To evaluate the function of AKAP150 in DRG neurons, we compared PKA-dependent modulation of TRPV1 in DRG neurons from WT mice and from mice expressing a mutated form of AKAP150 that lacks the PKA binding domain (⌬36 mice). TRPV1 phosphorylation by PKA can both sensitize the receptor (Lopshire and Nicol, 1998; Rathee et al., 2002) and decrease TRPV1 desensitization Mohapatra and Nau, 2003) , depending on the amino acid residue at which phosphorylation occurs (Mohapatra and Nau, 2005) . We found that stimulation of PKA with forskolin dramatically reduced TRPV1 desensitization in DRG neurons from WT mice but not in those from ⌬36 mice. Similarly, the ability of PGE 2 to prevent TRPV1 desensitization, and therefore to enhance receptor function during repeated stimulation, was strongly diminished in DRG neurons from ⌬36 mice. Furthermore, we found that the threshold temperature of heat-activated currents was markedly (ϳ8°C) reduced by PGE 2 and that this effect, as well as PGE 2 -induced thermal hyperalgesia, was significantly diminished in ⌬36 mice. These findings have several implications. First and most importantly, they support our hypothesis that PKA anchoring via AKAP150 is essential for mediating PGE 2 -induced modulation of TRPV1. This idea was corroborated by our rescue experiments, in which reintroduction of the AKAP79/150 PKA-binding site reconstituted the full PGE 2 effect on TRPV1 in DRG neurons from ⌬36 mice. Second, they show that the cAMP/PKA pathway is a major signaling cascade that mediates TRPV1 modulation by PGE 2 in DRG neurons. This is in good agreement with findings by others that PGE 2 exerts its effects on sensory neurons via EP3C and EP4 receptors, which are coupled through G s proteins to the activation of the cAMP/PKA signaling cascade (Hingtgen et al., 1995; Lopshire and Nicol, 1998; Southall and Vasko, 2001; Gu et al., 2003; Lin et al., 2006) . The residual effect of PGE 2 on TRPV1 in DRG neurons from ⌬36 mice could potentially be mediated by PGE 2 receptor subtypes that are coupled to the PKC-dependent pathway (Moriyama et al., 2005) , which was not impaired in ⌬36 mice (Fig. 5) .
In addition to PKA, AKAP150 also binds PKC and calcineurin (Coghlan et al., 1995; Klauck et al., 1996; Oliveria et al., 2003) . Both of these enzymes control the phosphorylation and functional status of TRPV1 (Bhave and Gereau, 2004; Tominaga and Tominaga, 2005) . It is therefore likely that AKAP150 integrates multiple enzymatic activities directed at TRPV1 to ensure highly localized and efficient regulation of the receptor phosphorylation. Another intriguing possibility is that AKAP150 links TRPV1 and PKA to receptors for PGE 2 and other inflammatory mediators. The ability of AKAPs to bring receptors and their effectors together with other signaling components is not unprecedented. For example, AKAP79/150 is central for the assembly and function of a multiprotein complex consisting of ␤-adrenergic receptor, G s -protein, adenylyl cyclase, AKAP79/150, and L-type Ca 2ϩ channels (Gao et al., 1997; Davare et al., 2001; Hall et al., 2007) . Another example is an AKAP150 signaling complex that couples acetylcholine muscarinic receptors with M-type (KCNQ2/3) K ϩ channels via G q -proteins and PKC (Hoshi et al., 2003) . Such molecular arrangements enable highly specific receptor-toeffector signaling despite the broad substrate specificities of PKA and PKC. Future studies will determine whether similar receptorto-effector multiprotein signaling complexes are assembled around AKAP150 and TRPV1 to regulate the phosphorylation and activity of the capsaicin receptor.
TRPV1 phosphorylation has multiple functional consequences. Several inflammatory mediators, such as bradykinin, serotonin, and ATP, as well as pharmacological activators of PKA and PKC, reduce threshold temperature of heat-activated currents in sensory neurons and in TRPV1-expressing HEK293 cells via PKA-and PKC-dependent phosphorylation of the receptor (Tominaga et al., 2001; Rathee et al., 2002; Sugiura et al., 2002 Sugiura et al., , 2004 Moriyama et al., 2005) . This, in turn, can contribute to thermal hyperalgesia in response to tissue injury or inflammation observed in animal models (Caterina et al., 2000; Davis et al., 2000) . A similar mechanism is likely involved in the development of PGE 2 -induced thermal hyperalgesia (Malmberg et al., 1997; Yang and Gereau, 2002; Moriyama et al., 2005) . Indeed, we found that PGE 2 decreased the threshold temperature of heat-activated currents by ϳ8°C in mouse DRG neurons and that this response was partially mediated by AKAP150-anchored PKA (Fig. 9) . A similar PGE 2 -induced shift in temperature dependence was reported in TRPV1-expressing HEK293 cells (Moriyama et al., 2005) .
Another consequence of TRPV1 phosphorylation is its reduced desensitization, which can facilitate function of the receptor during continuous stimulation by protons in inflamed tissue and might be responsible for chronic pain associated with arthritis, irritable bowel syndrome, and bone cancer (Ghilardi et al., 2005; Jones et al., 2005; Keeble et al., 2005; Szabo et al., 2005) . Enhanced Ca 2ϩ influx through phosphorylated TRPV1 can also contribute to facilitated release of substance P and calcitonin gene-related peptide from peripheral nociceptive terminals and to the development of neurogenic inflammation (Richardson and Vasko, 2002) . Thus, phosphorylation of TRPV1 triggers a concerted activation of multiple signaling pathways that lead to increased nociceptor excitability and pain hypersensitivity. Accordingly, targeting the TRPV1 phosphorylation machinery, and specifically the TRPV1-AKAP150 -PKA interaction, may help to selectively alleviate the hyperalgesic action of TRPV1 while minimally affecting such physiological functions of TRPV1 as thermosensation and thermoregulation (Caterina et al., 2000; Gavva et al., 2007) . Our finding that disruption of the AKAP150 -PKA complex diminishes PGE 2 -induced thermal hyperalgesia but does not affect thermal sensitivity under basal conditions (Fig.  9F ) supports this concept.
In summary, we have shown that, in mouse DRG neurons, AKAP150 is a major PKA-anchoring protein involved in PGE 2 / PKA-dependent TRPV1 modulation. AKAP150 may prove to serve as a molecular hub for the TRPV1 phosphorylation complex, thereby contributing to the specificity and efficiency with which the receptor is regulated by inflammatory mediators and their downstream signaling pathways.
